# Role of Biomarkers in Muscle Pain and Joint Pain in Patients With Solid Tumors Receiving Paclitaxel

> **NCT01096407** · — · TERMINATED · sponsor: **Vanderbilt-Ingram Cancer Center** · enrollment: 5 (actual)

## Conditions studied

- Arthralgia
- Pain
- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **OTHER:** laboratory biomarker analysis
- **OTHER:** questionnaire administration
- **PROCEDURE:** assessment of therapy complications

## Key facts

- **NCT ID:** NCT01096407
- **Lead sponsor:** Vanderbilt-Ingram Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2009-11
- **Primary completion:** 2010-11
- **Final completion:** 2010-11
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** slow accrual
- **Last updated:** 2013-04-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01096407

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01096407, "Role of Biomarkers in Muscle Pain and Joint Pain in Patients With Solid Tumors Receiving Paclitaxel". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01096407. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*